168 related articles for article (PubMed ID: 37542661)
1. CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients.
Shamsi A; Roghani SA; Abdan Z; Soufivand P; Pournazari M; Bahrehmand F; Vafaei A; Salari N; Soroush MG; Taghadosi M
Inflammation; 2023 Dec; 46(6):2374-2385. PubMed ID: 37542661
[TBL] [Abstract][Full Text] [Related]
2. CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
Shamsi A; Roghani SA; Soufivand P; Pournazari M; Khoobbakht F; Bahrehmand F; Taghadosi M
Clin Rheumatol; 2024 Jan; 43(1):137-145. PubMed ID: 38006573
[TBL] [Abstract][Full Text] [Related]
3. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.
Ruschpler P; Lorenz P; Eichler W; Koczan D; Hänel C; Scholz R; Melzer C; Thiesen HJ; Stiehl P
Arthritis Res Ther; 2003; 5(5):R241-52. PubMed ID: 12932287
[TBL] [Abstract][Full Text] [Related]
4. [Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis].
Zhong H; Xu LL; Bai MX; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1026-1031. PubMed ID: 34916676
[TBL] [Abstract][Full Text] [Related]
5. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.
Yoon KC; Park CS; You IC; Choi HJ; Lee KH; Im SK; Park HY; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):643-50. PubMed ID: 19850844
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis and the Th1 chemokine MIG.
Paparo SR
Clin Ter; 2019; 170(6):e472-e477. PubMed ID: 31696912
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts.
Tsubaki T; Takegawa S; Hanamoto H; Arita N; Kamogawa J; Yamamoto H; Takubo N; Nakata S; Yamada K; Yamamoto S; Yoshie O; Nose M
Clin Exp Immunol; 2005 Aug; 141(2):363-71. PubMed ID: 15996201
[TBL] [Abstract][Full Text] [Related]
10. The role of CXCR3 and its ligands expression in Brucellar spondylitis.
Hu X; Shang X; Wang L; Fan J; Wang Y; Lv J; Nazierhan S; Wang H; Wang J; Ma X
BMC Immunol; 2020 Nov; 21(1):59. PubMed ID: 33208100
[TBL] [Abstract][Full Text] [Related]
11. CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis.
Laragione T; Brenner M; Sherry B; Gulko PS
Arthritis Rheum; 2011 Nov; 63(11):3274-83. PubMed ID: 21811993
[TBL] [Abstract][Full Text] [Related]
12. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
Schroepf S; Kappler R; Brand S; Prell C; Lohse P; Glas J; Hoster E; Helmbrecht J; Ballauff A; Berger M; von Schweinitz D; Koletzko S; Lacher M
Inflamm Bowel Dis; 2010 Nov; 16(11):1882-90. PubMed ID: 20848514
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Verhulst SJ; Ransohoff RM
Clin Exp Immunol; 2013 Jun; 172(3):427-36. PubMed ID: 23600831
[TBL] [Abstract][Full Text] [Related]
14. Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis.
Iwata S; Zhang M; Hajime M; Ohkubo N; Sonomoto K; Torimoto K; Kitanaga Y; Trimova G; Todoroki Y; Miyata H; Ueno M; Nagayasu A; Kanda R; Nakano K; Nakayamada S; Sakata K; Tanaka Y
Rheumatology (Oxford); 2021 Nov; 60(11):5452-5462. PubMed ID: 33693564
[TBL] [Abstract][Full Text] [Related]
15. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
Menke J; Zeller GC; Kikawada E; Means TK; Huang XR; Lan HY; Lu B; Farber J; Luster AD; Kelley VR
J Am Soc Nephrol; 2008 Jun; 19(6):1177-89. PubMed ID: 18337479
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of chemokine CXC receptor 3, 4 and their ligands at the early pregnancy decidua and villi].
Bai XX; Kong BH; Zhang YZ; Qu X; Wang HL
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):904-8. PubMed ID: 19134328
[TBL] [Abstract][Full Text] [Related]
17. The Serum Level of CXCL9, CXCL10, and CXCL11 and the Expression of CXCR3 of Peripheral Blood Mononuclear Cells in Brucellosis Patients.
Hassanshahi F; Noroozi Karimabad M; Miranzadeh E; Hassanshahi G; Torabizadeh SA; Jebali A
Curr Microbiol; 2023 May; 80(6):201. PubMed ID: 37140634
[TBL] [Abstract][Full Text] [Related]
18. EBV-positive pyothorax-associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3.
Higuchi T; Hashida Y; Matsuo K; Kitahata K; Ujihara T; Murakami I; Nakayama T; Daibata M
Cancer Sci; 2023 Jun; 114(6):2622-2633. PubMed ID: 36898851
[TBL] [Abstract][Full Text] [Related]
19. T helper cells in synovial fluid of patients with rheumatoid arthritis primarily have a Th1 and a CXCR3
Aldridge J; Ekwall AH; Mark L; Bergström B; Andersson K; Gjertsson I; Lundell AC; Rudin A
Arthritis Res Ther; 2020 Oct; 22(1):245. PubMed ID: 33066816
[TBL] [Abstract][Full Text] [Related]
20. The CXCL9/10/11-CXCR3 axis as a predictor of COVID-19 progression: a prospective, case-control study.
Çelik N; Çelik O; Laloğlu E; Özkaya A
Rev Soc Bras Med Trop; 2023; 56():e01282023. PubMed ID: 37493737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
